Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Adherence and Anti retroviral Therapy in Injection Drug Users

Article Abstract:

Physicians may need to make a special effort to ensure that HIV-infected drug addicts receive antiretroviral therapy. Two 1998 studies showed that this group of patients is less likely to receive these drugs even when they are offered free of charge. Patients must be told that these drugs are crucial to their long-term health provided that they take the pills regularly. Treatment compliance can be enhanced in many ways and these patients should be closely monitored. HIV-infected drug addicts have similar outcomes as other HIV patients when they have a stable relationship with a primary care physician and access to support services.

Author: Sherer, Renslow MD
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Self-reported Antiretroviral Therapy in Injection Drug Users

Article Abstract:

Intravenous drug users may not be getting the most effective drug treatments for HIV infection. Researchers surveyed 404 HIV-infected intravenous drug users attending a community-based clinic between July 1996 and June 1997. Half of the patients were not receiving antiretroviral drugs. Only 14% were taking triple-combination therapy that included a protease inhibitor, which is the treatment currently recommended by the US Public Health Service. Patients who received regular health care and were in drug treatment programs were the most likely to be receiving proper HIV treatment.

Author: Celentano, David D. ScD, MHS, Vlahov, David PhD, Cohn, Sylvia MS, Shadle, Vera M. MHS, Obasanjo, Olugbenga MBBS, MPH, Moore, Richard D. MD, MHS
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users

Article Abstract:

Many HIV-infected drug users in British Columbia are not receiving antiretroviral treatment even though the province provides this treatment free of charge to those who qualify. Of 177 eligible drug users recruited for treatment, only 40% had received treatment an average of 11 months after becoming eligible. Women were less likely to receive treatment as were those not in a drug treatment program and those whose doctors had less experience treating HIV patients. Young addicts were also less likely to receive treatment.

Author: Strathdee, Steffanie A. PhD, Palepu, Anita MD, MPH, Cornelisse, Peter G.A. MSc, Yip, Benita BSc (Pharm), O'Shaughnessy, Michael V. OBC, PhD, Montaner, Julio S. G. MD, FRCPC, Schechter, Martin T. OBC, MD, PhD
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Social policy, British Columbia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, HIV infection, Drug therapy, HIV infections, Drug addicts, Drug abusers
Similar abstracts:
  • Abstracts: Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance, Part 4. Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance, Part 1
  • Abstracts: A voluntary serosurvey and behavioral risk assessment for human immunodeficiency virus infection among college students
  • Abstracts: Women's Health and Human Rights in Afghanistan. part 2
  • Abstracts: Heard the one about the nurse and the engineer? Who'd be a steward?: They may be able to advise nurses on rights and negotiate on pay, but RCN stewards know little about employment law and even RCN policies. So what is being done to remedy this?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.